For its 10th anniversary, the small Brussels company Imagilys (5 people) was selected by the American leader in clinical trials (15,000 people worldwide), nose and beard much bigger competitors. Imagilys develops and sells specialized neuro-imaging software enabling the diagnosis and cure of patients with severe neurological, neurosurgical and psychiatric diseases.
The American leader, Parexel, signed a contract with Imagilys for the use of its BrainMagix Software for Multiple Sclerosis and Alzheimers disease. The main goal of this collaboration is the use the software to test new drugs for these two affections.
In the meantime, Imagilys also launches its new Advanced Clinical Neuro-imaging Course, taking place on May 21-22 in Brussels.
This member of the cluster clearly has the wind in its sails. We wish Imagilys an Happy Birthday and much more good news to come!